![Ariel Feldstein](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Ariel Feldstein is currently a Director at Elgia Therapeutics, Inc. He was previously a Director at Jecure Therapeutics, Inc. from 2016 to 2018.
| Unternehmen | Position | Beginn |
|---|---|---|
Elgia Therapeutics, Inc.
 Elgia Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Provides pharmaceutical services | Direktor/Vorstandsmitglied | - |
| Unternehmen | Position | Ende |
|---|---|---|
Jecure Therapeutics, Inc.
 Jecure Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Engages in research of therapeutics for the treatment of non-alcoholic steatohepatitis (NASH) and liver fibrosis | Direktor/Vorstandsmitglied | 01.01.2018 |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
| Private Unternehmen | 2 |
|---|---|
Jecure Therapeutics, Inc.
Jecure Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Engages in research of therapeutics for the treatment of non-alcoholic steatohepatitis (NASH) and liver fibrosis | Commercial Services |
Elgia Therapeutics, Inc.
Elgia Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Provides pharmaceutical services | Health Technology |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen
